Literature DB >> 10421119

Reduction of intimal and medial thickening in sheathed vein grafts.

H R Zurbrügg1, M Wied, G D Angelini, R Hetzer.   

Abstract

BACKGROUND: Arterial pressures are described as an important factor in the development of graft degeneration and in reduced patency rate in vein bypass grafts. Sheathing of the graft with a pressure resistant mesh tubing might slow down this development.
METHODS: Saphenous vein grafts were implanted into the carotid arteries of five pigs in order to evaluate the influence on myointimal hyperplasia of a compliant Phynox mesh tubing (a wrought Cobalt-Chromium-Nickel-Molybdenum-Iron Alloy), which surrounded autologous vein grafts that were exposed to arterial pressure. Each pig was operated on using a sheathed vein graft (biocompound-graft, a hybrid vascular prosthesis) on one side and an untreated saphenous vein on the other.
RESULTS: After 4 weeks intimal hyperplastic changes were found in all histological sections. The wall thickness (medial and intimal layer) varied from 351 microm to 432 microm in the biocompound-graft and from 391 microm to 1196 microm in the native vein grafts (p < 0.05, n = 5). Severe myocytial and fibroblast proliferation was only found in the control grafts. Cellularity of the medial layer differed at sites of maximal cellular density and ranged from 11 to 12 cells in the biocompound-graft and from 17 to 18 cells per counting field in the native vein grafts (p < 0.05, n = 5).
CONCLUSIONS: External support of vein grafts reduces intimal and medial layer proliferation. The findings of this study are in accordance with the results reported by other research groups.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421119     DOI: 10.1016/s0003-4975(99)00452-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Functional remodeling of an electrospun polydimethylsiloxane-based polyether urethane external vein graft support device in an ovine model.

Authors:  Mohammed El-Kurdi; Lorenzo Soletti; Jonathan McGrath; Stephen Linhares; Serge Rousselle; Howard Greisler; Elazer Edelman; Frederick J Schoen
Journal:  J Biomed Mater Res A       Date:  2019-05-27       Impact factor: 4.396

Review 2.  Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures.

Authors:  Timothy C Boire; Daniel A Balikov; Yunki Lee; Christy M Guth; Joyce Cheung-Flynn; Hak-Joon Sung
Journal:  Macromol Rapid Commun       Date:  2016-09-27       Impact factor: 5.734

3.  A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal-medial hyperplasia in an experimental canine model.

Authors:  Atsuhiko Sato; Shunsuke Kawamoto; Mika Watanabe; Yusuke Suzuki; Goro Takahashi; Naoki Masaki; Kiichiro Kumagai; Yoshifumi Saijo; Koichi Tabayashi; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-09-29

Review 4.  Novel no touch technique of saphenous vein harvesting: Is great graft patency rate provided?

Authors:  Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; John Goudevenos; George Papadopoulos; Efstratios Apostolakis
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep

5.  Neointima development in externally stented saphenous vein grafts. Progress in medicine is good for the patient: why not use total arterial revascularization?: Response to the Letter to the Editor: Neointima development in externally stented saphenous vein grafts. External stents are bad for the patient: why not use an undamaged saphenous vein for coronary artery bypass graft?

Authors:  Michał Krejca; Przemysław Węglarz; Maria Trusz-Gluza; Krystyna Bochenek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

Review 6.  Review of risk factors, treatment, and prevention of saphenous vein graft disease after coronary artery bypass grafting.

Authors:  Jing Gao; Yin Liu; Yu-Ming Li
Journal:  J Int Med Res       Date:  2018-09-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.